Vaccine | Image for representational purpose (Photo Credits: Pixabay)
Zurich, December 19: Switzerland on Saturday announced its approval for using the vaccine against coronavirus (COVID-19), which is developed by Pfizer and partner BioNTech. Swiss drugs regulator Swissmedic announced its official website that Pfizer-BioNTech s COVID-19 vaccine has been authorised for use in Switzerland following a two-month rolling review. According to the data assessed by the Swiss Agency for Therapeutic Products, the level of protection afforded seven days after the second injection of the vaccine is over 90 percent. This represents the world s first authorisation in the ordinary procedure, Swissmedic said. So far, the United States, Britain, Canada, Saudi Arabia and Bahrain authorised Pfizer-BioNTech s COVID-19 vaccine.
Saturday, 19 Dec 2020 06:35 PM MYT
Swiss drugs regulator authorises Pfizer/Biontech Covid-19 vaccine. AFP pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
ZURICH, Dec 19 ― Swiss drugs regulator Swissmedic has authorised the Covid-19 vaccine from Pfizer and partner BioNTech, the agency said today, calling it the world s first such approval under a standard procedure.
Two months after receiving the application, Swissmedic granted authorisation for the vaccine in a rolling review of documents being submitted.
Other countries have already approved it for emergency use to help curb the global coronavirus pandemic.
“The data available to date showed a comparable high level of efficacy in all investigated age groups, thus meeting the safety requirements,” it said on its website.
US State Senator Jerry Relph dies after Covid-19 diagnosis
From CNN s Hollie Silverman
Republican Minnesota State Senator Jerry Relph. Minnesota State Legislature
Republican Minnesota State Senator Jerry Relph has died, a statement from his family said Friday night.
Relph, 76, had been diagnosed with Covid-19 after discovering he was exposed at the State Capitol and had been admitted to an emergency room for his symptoms, CNN affiliate WCCO reported.
He died Friday, according to the family statement.
“I m heartbroken to share that my husband, Jerry Relph, has passed away and entered his heavenly home, his wife Pegi Broker-Relph said in the statement.
First Covid-19 vaccine approved for Swiss use
The Covid-19 vaccine from Pfizer/BioNTech is one of three pre-ordered by the Swiss health authorities. Switzerland expects to start vaccinating the most vulnerable people this month already, and nationwide from January 4. Tampa Bay Times
Swiss health regulator Swissmedic has approved the coronavirus vaccine from Pfizer/BioNTech. According to the Swiss authorities, the level of protection is over 90% a week after the second dose.
This content was published on December 20, 2020 - 10:40
December 20, 2020 - 10:40
swissinfo.ch/sm
Two months after receiving the application, Swissmedic, the Swiss Agency for Therapeutic Products, has given the coronavirus vaccine Comirnaty® (BNT162b2) the green light. Based on the available data, the agency found a comparably high level of efficacy in all age groups that were tested.
Pfizer-BioNtech COVID-19 vaccine wins Swiss regulatory approval Toggle share menu
Advertisement
Pfizer-BioNtech COVID-19 vaccine wins Swiss regulatory approval
FILE PHOTO: Personal support worker Johanne Lamesse reacts in anticipation to the needle as she receives the Pfizer-BioNTech COVID-19 vaccine at the Civic Hospital in Ottawa, Ontario, Canada on Dec 15, 2020. (Photo: Adrian Wyld/Pool via REUTERS)
19 Dec 2020 06:49PM (Updated:
19 Dec 2020 10:32PM) Share this content
Bookmark
ZURICH: Swiss drugs regulator Swissmedic has authorised the COVID-19 vaccine from Pfizer and partner BioNTech, the agency said on Saturday (Dec 19), calling it the world s first such approval under a standard procedure.
Two months after receiving the application, Swissmedic granted authorisation for the vaccine for people aged 16 and older after a rolling review of documents being submitted.